US Physical Therapy
The 10-second takeaway
For the quarter ended June 30 (Q2), US Physical Therapy met expectations on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue increased and GAAP earnings per share was unchanged.
Margins dropped across the board.
US Physical Therapy reported revenue of $64.0 million. The six analysts polled by S&P Capital IQ hoped for revenue of $63.9 million on the same basis. GAAP reported sales were 6.8% higher than the prior-year quarter's $59.9 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.41. The six earnings estimates compiled by S&P Capital IQ forecast $0.44 per share. GAAP EPS of $0.41 were the same as the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 28.6%, 40 basis points worse than the prior-year quarter. Operating margin was 16.6%, 160 basis points worse than the prior-year quarter. Net margin was 7.6%, 60 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $63.2 million. On the bottom line, the average EPS estimate is $0.38.
Next year's average estimate for revenue is $252.9 million. The average EPS estimate is $1.55.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 245 members out of 249 rating the stock outperform, and four members rating it underperform. Among 72 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 70 give US Physical Therapy a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on US Physical Therapy is buy, with an average price target of $29.50.
- Add US Physical Therapy to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.